Recombinant human serum albumin (OsrHSA) has emerged as a big innovation in the sector of biopharmaceuticals, presenting promising progress across various healthcare and industrial purposes. With its structural similarity to In a natural way derived human serum albumin, OsrHSA supplies a safer, additional responsible alternative for therapeutic use